Overview
The present study will evaluate the effectiveness of Buzzy Bee in reducing pain and physiological responses during maxillary buccal infiltration in children aged 5-7 years compared with a conventional injection protocol.
Description
Pain control during local anesthetic administration is essential in pediatric dentistry, as injection-related discomfort may increase anxiety and affect children's cooperation. The present study will evaluate the effectiveness of Buzzy Bee in reducing pain and physiological responses during maxillary buccal infiltration in children aged 5-7 years compared with a conventional injection protocol.
The study includes 40 children attending the Outpatient Clinic of the Pediatric Dentistry Department, Faculty of Dentistry, Tanta University. A randomized crossover design will be used, with each child receiving both interventions during two visits separated by one week. Participants will be randomly allocated to the AB or BA sequence.
Both interventions involved topical application of 4% lidocaine hydrochloride gel for two minutes, followed by maxillary buccal infiltration using 4% articaine with epinephrine 1:200,000. The Buzzy Bee protocol incorporated external cold and vibration, whereas the conventional protocol used audiovisual distraction.
Heart rate will be recorded before, during, and after injection. Pain will be assessed using the Face, Legs, Activity, Cry, Consolability (FLACC) scale and the Wong-Baker Faces Pain Rating Scale.
Eligibility
Inclusion Criteria:
- Systemically healthy children classified as ASA-I.
- Children requiring bilateral maxillary buccal infiltration local anesthesia across at least two separate dental treatment appointments.
- Co-operative child with a Frankl behavior rating of 3,4.
- Children free from any neurological or psychological disorder.
Exclusion Criteria:
- Children with known allergy to local anesthetic agents.
- Children with developmental delays, intellectual disabilities, or severe uncooperative behavior (Frankl rating 1 or 2).
- Children presenting with acute dental pain, swelling, or active infection at the injection site.
- Parental refusal to provide written informed consent for participation
